159 related articles for article (PubMed ID: 29142464)
1. BMPR2 and HIF1-
Wang S; Ren T; Huang Y; Bao X; Sun K; Shen D; Guo W
Chin J Cancer Res; 2017 Oct; 29(5):447-454. PubMed ID: 29142464
[TBL] [Abstract][Full Text] [Related]
2. Association of JMJD2B and Hypoxia-Inducible Factor 1 Expressions with Poor Prognosis in Osteosarcoma.
Liu X; Zhang Q; Zhao Y; Xun J; Wu H; Feng H
Anal Cell Pathol (Amst); 2020; 2020():2563208. PubMed ID: 32802732
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of hypoxia-inducible factor 1 and VEGF-A in osteosarcoma.
Zhao H; Wu Y; Chen Y; Liu H
Int J Clin Oncol; 2015 Dec; 20(6):1233-43. PubMed ID: 26077139
[TBL] [Abstract][Full Text] [Related]
4. BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma.
Cao H; Quan S; Zhang L; Chen Y; Jiao G
Oncol Lett; 2021 May; 21(5):391. PubMed ID: 33777214
[TBL] [Abstract][Full Text] [Related]
5. BMPR2 promotes invasion and metastasis via the RhoA-ROCK-LIMK2 pathway in human osteosarcoma cells.
Wang S; Ren T; Jiao G; Huang Y; Bao X; Zhang F; Liu K; Zheng B; Sun K; Guo W
Oncotarget; 2017 Aug; 8(35):58625-58641. PubMed ID: 28938584
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of the VHL, HIF-1α, and VEGF Signaling Pathway and Associated MAPK (ERK1/2 and ERK5) Pathways in Clear-Cell Renal Cell Carcinoma. A Long-Term Study.
Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SY; Roche-Losada O; Sánchez-Prieto R; Giménez-Bachs JM
Clin Genitourin Cancer; 2017 Dec; 15(6):e923-e933. PubMed ID: 28624320
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analysis of the Genetic and Epigenetic Alterations of Bone Morphogenetic Protein Receptors in Metastatic Breast Cancer.
Hermawan A; Putri H
Biochem Genet; 2024 Apr; 62(2):594-620. PubMed ID: 37486509
[TBL] [Abstract][Full Text] [Related]
9. Effect of miRNA-200a on radiosensitivity of osteosarcoma cells by targeting Bone morphogenetic protein receptor 2.
Tao X; Cheng J; Wang X
Bioengineered; 2021 Dec; 12(2):12625-12635. PubMed ID: 34903128
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-335 and its target Rock1 synergistically influence tumor progression and prognosis in osteosarcoma.
Wang Y; Wang N; Zeng X; Sun J; Wang G; Xu H; Zhao W
Oncol Lett; 2017 May; 13(5):3057-3065. PubMed ID: 28521412
[TBL] [Abstract][Full Text] [Related]
11. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma.
Ren Z; Liang S; Yang J; Han X; Shan L; Wang B; Mu T; Zhang Y; Yang X; Xiong S; Wang G
Tumour Biol; 2016 Apr; 37(4):5089-96. PubMed ID: 26546437
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic significance of S100A4 expression in osteosarcoma.
Cao CM; Yang FX; Wang PL; Yang QX; Sun XR
Eur Rev Med Pharmacol Sci; 2014; 18(6):833-9. PubMed ID: 24706307
[TBL] [Abstract][Full Text] [Related]
14. Expression of mutant bone morphogenetic protein receptor II worsens pulmonary hypertension secondary to pulmonary fibrosis.
Bryant AJ; Robinson LJ; Moore CS; Blackwell TR; Gladson S; Penner NL; Burman A; McClellan LJ; Polosukhin VV; Tanjore H; McConaha ME; Gleaves LA; Talati MA; Hemnes AR; Fessel JP; Lawson WE; Blackwell TS; West JD
Pulm Circ; 2015 Dec; 5(4):681-90. PubMed ID: 26697175
[TBL] [Abstract][Full Text] [Related]
15. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
[TBL] [Abstract][Full Text] [Related]
16. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
Zheng B; Ren T; Huang Y; Guo W
Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma.
Huang H; Zheng HY; Liu ZL; Zhang L
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2828-34. PubMed ID: 25339476
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the expression of aquaporin 1 and hypoxia-inducible factor 1 in breast cancer tissues.
Yin T; Yu S; Xiao L; Zhang J; Liu C; Lu Y; Liu C
J Huazhong Univ Sci Technolog Med Sci; 2008 Jun; 28(3):346-8. PubMed ID: 18563339
[TBL] [Abstract][Full Text] [Related]
19. Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome.
Arlt MJ; Kuzmanov A; Snedeker JG; Fuchs B; Silvan U; Sabile AA
BMC Cancer; 2019 Jan; 19(1):83. PubMed ID: 30654764
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor 1-alpha up-regulates the expression of phospholipase D2 in colon cancer cells under hypoxic conditions.
Liu M; Du K; Fu Z; Zhang S; Wu X
Med Oncol; 2015 Jan; 32(1):394. PubMed ID: 25432699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
